Stay updated on Lomvastomig in Solid Tumors Dose Escalation Clinical Trial

Sign up to get notified when there's something new on the Lomvastomig in Solid Tumors Dose Escalation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lomvastomig in Solid Tumors Dose Escalation Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A new revision entry (v3.4.3) was added and the previous revision (v3.4.2) was removed from the study record history.
    Difference
    0.1%
    Check dated 2026-03-11T23:26:28.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed older notices including Revision: v3.4.1. These are administrative updates to the site history and do not change core study information or user-facing content.
    Difference
    0.4%
    Check dated 2026-02-11T10:57:47.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page now displays a government-funding notice and updates the site revision to v3.4.1, replacing the previous v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T06:21:31.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Introduces a Show glossary option and color-coded highlights for additions and deletions in the study record history, with revision notes updated to v3.4.0 and removal of 'No FEAR Act data'.
    Difference
    0.5%
    Check dated 2026-01-28T04:35:21.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The history page now includes a new revision entry (v3.3.4) and removes the previous v3.3.3, reflecting an administrative update to the record.
    Difference
    0.1%
    Check dated 2026-01-14T01:14:38.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    New revision notice added: Revision: v3.3.3, and Revision: v3.3.2 removed, along with deletion of the HHS Vulnerability Disclosure link in the footer; these are routine maintenance updates that do not affect study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T12:30:20.000Z thumbnail image

Stay in the know with updates to Lomvastomig in Solid Tumors Dose Escalation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lomvastomig in Solid Tumors Dose Escalation Clinical Trial page.